OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent‐4en and but‐3en analogues including MDMB‐4en‐PINACA
Alex J. Krotulski, Annelies Cannaert, Christophe P. Stove, et al.
Drug Testing and Analysis (2020) Vol. 13, Iss. 2, pp. 427-438
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances
Stefania Chiappini, Giorgia Vaccaro, Alessio Mosca, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105691-105691
Open Access | Times Cited: 15

NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches
Giorgia Vaccaro, Anna Massariol, Amira Guirguis, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 8, pp. 1350-1367
Open Access | Times Cited: 38

Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review
M. Oliveira, Mariana Capelo Vides, Dângela Layne Silva Lassi, et al.
Brain Sciences (2023) Vol. 13, Iss. 7, pp. 990-990
Open Access | Times Cited: 31

New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic
Alfredo Fabrizio Lo Faro, Diletta Berardinelli, Tommaso Cassano, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 273-273
Open Access | Times Cited: 22

Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB1 receptor
Beth Ryalls, Monica Patel, Eric Sparkes, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116052-116052
Open Access | Times Cited: 9

The metabolism of the synthetic cannabinoids ADB‐BUTINACA and ADB‐4en‐PINACA and their detection in forensic toxicology casework and infused papers seized in prisons
Robert Kronstrand, Caitlyn Norman, Svante Vikingsson, et al.
Drug Testing and Analysis (2021) Vol. 14, Iss. 4, pp. 634-652
Open Access | Times Cited: 49

Notes from the Field: Cluster of Severe Illness from Neptune’s Fix Tianeptine Linked to Synthetic Cannabinoids — New Jersey, June–November 2023
Christopher Counts, Anthony V. Spadaro, Trevor Cerbini, et al.
MMWR Morbidity and Mortality Weekly Report (2024) Vol. 73, Iss. 4, pp. 89-90
Open Access | Times Cited: 6

Adulteration of low‐delta‐9‐tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services
Manuela Carla Monti, Jill Zeugin, Konrad R. Koch, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 6, pp. 1026-1039
Open Access | Times Cited: 25

Fatal cases involving new psychoactive substances and trends in analytical techniques
E. Ferrari, Bruno Henrique Monteiro Leite, Eliude Barbosa Gomes, et al.
Frontiers in Toxicology (2022) Vol. 4
Open Access | Times Cited: 24

The Resurgence of Synthetic Cannabinoid Receptor Agonists as Adulterants in the Era of Cannabis Legalization: Lessons from Prior Epidemics and Clinical Implications
Aaron P. Jones, Ali S. Taha, Grover P. Miller
Neuroscience & Biobehavioral Reviews (2025), pp. 106043-106043
Closed Access

An Outbreak of Synthetic Cannabinoid-Adulterated Tianeptine Products in New Jersey – Case Series
Christopher Counts, Anthony V. Spadaro, Trevor Cerbini, et al.
Journal of Medical Toxicology (2025)
Open Access

Ciências Forenses: Aplicações Científicas na Criminalística
Samara Alves Testoni, Cláudio M. P. Pereira, Rafael Scorsatto Ortiz
Revista Brasileira de Criminalística (2025) Vol. 14, Iss. 1, pp. 77-77
Open Access

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
Valeria Catalani, Davide Arillotta, John Corkery, et al.
Frontiers in Psychiatry (2021) Vol. 11
Open Access | Times Cited: 31

Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions
Joshua D. Brown, Kevin J. Rivera Rivera, Leilanie Y. Crespo Hernandez, et al.
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 29

Synthetic cannabinoid receptor agonists are monoamine oxidase‐A selective inhibitors
Sarah A. Hindson, Rachael Andrews, Michael J. Danson, et al.
FEBS Journal (2023) Vol. 290, Iss. 12, pp. 3243-3257
Open Access | Times Cited: 11

Zebrafish Embryo-Larval Testing Reveals Differential Toxicity of New Psychoactive Substances
Leonardo Costalonga Rodrigues, Alexandre B. Godoi, Viviane Cristina Fais, et al.
Toxicology Reports (2025), pp. 102018-102018
Open Access

Interpol Review of Drug Analysis 2019-2022
David J. Love, Nicole S. Jones
Forensic Science International Synergy (2023) Vol. 6, pp. 100299-100299
Open Access | Times Cited: 10

Fatal Overdose with the Cannabinoid Receptor Agonists MDMB-4en-PINACA and 4F-ABUTINACA: A Case Report and Review of the Literature
Gábor Simon, Mónika Kuzma, Mátyás Mayer, et al.
Toxics (2023) Vol. 11, Iss. 8, pp. 673-673
Open Access | Times Cited: 10

Pharmacological evaluation of new generation OXIZID synthetic cannabinoid receptor agonists
Monica Patel, Xiaoxi Zheng, Luli R. Akinfiresoye, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176549-176549
Open Access | Times Cited: 3

Biosynthetic origins of unusual cannabimimetic phytocannabinoids in Cannabis sativa L: A review
Matthew T. Welling, Myrna A. Deseo, Antony Bacic, et al.
Phytochemistry (2022) Vol. 201, pp. 113282-113282
Closed Access | Times Cited: 14

New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl‐CBMICA and Cumyl‐CBMINACA
Belal Haschimi, Katharina Elisabeth Grafinger, Benedikt Pulver, et al.
Drug Testing and Analysis (2021) Vol. 13, Iss. 8, pp. 1499-1515
Closed Access | Times Cited: 18

Page 1 - Next Page

Scroll to top